Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105111228A reveals a novel 5,5'-tetralone chiral phosphoric acid with superior acidity and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN114539198B reveals novel amide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed route for complex ketene imines via enynone insertion. Mild conditions, high atom economy. Ideal for API intermediates and fine chemical manufacturing scale-up.
Patent CN106083649B details a novel two-step synthesis for cyclohexadiene derivatives, offering significant cost reduction and high yields for pharmaceutical intermediates manufacturing.
Novel FeCl3-catalyzed route offers high yields and scalability for drug intermediates, reducing costs in API manufacturing significantly.
Novel Ru-catalyzed transfer hydrogenation method for 3-acylpyrroles. High atom economy, scalable process for reliable pharmaceutical intermediate supply and cost reduction.
Novel palladium-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrol-2-one compounds offers high efficiency and simplified supply chains for pharmaceutical manufacturing.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.
Patent CN108586527B reveals a metal-free visible light method for aryl phosphonates. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable green synthesis.
Patent CN113195460A details enantioselective iridium-catalyzed hydrogenation of oximes. This breakthrough offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Patent CN106699600B reveals Fe-catalyzed decarboxylation. Safe, green, cost-effective route for pharmaceutical intermediates.
Patent CN105906506B details a novel Pd-catalyzed route for alpha-acetoxy-enones, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN112209867B details a robust Rh-catalyzed C-H activation route for 2-alkynyl indoles, offering cost reduction in API manufacturing and scalable production.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl imidazoles offers high efficiency and scalability for pharmaceutical intermediates.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel metal-free oxidative cyclization route for triazole intermediates. High yield, scalable process for pharmaceutical applications reducing heavy metal waste.
Patent CN108658841B reveals a mild Rh-catalyzed route to carbazoles from boronic acids and azides, offering cost reduction in electronic chemical manufacturing.
Patent CN113121462B reveals a metal-free route for 5-trifluoromethyl-1,2,3-triazoles, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112409236B introduces a green sulfonyl hydrazide route for 3-thioether indoles, offering cost-effective and scalable solutions for API manufacturing.